Jesus-Nunes AP, Morais-de-Jesus M, Dantas-Duarte A, Miranda MT, Coelho AF, de Oliveira CA, Evangelista MA, Codes L, Lisboa BP, Quarantini LC

Language: English
References: 28
Page: 104-109
PDF size: 145.29 Kb.

ABSTRACT

Introduction and aim. Transplant recipients are chronically ill patients who rely on medical treatment throughout life to achieve positive results. Despite that, medication nonadherence after liver transplantation is extremely common. The self-report, one of several methods for measuring adherence, is easy to apply and low cost. Thus, this study aims to translate and validate the Immunosuppressant Therapy Adherence Instrument (ITAS) in Brazilian Portuguese for liver transplant recipients. Material and methods. A total of 139 liver transplant recipients were selected from a general hospital, who were assessed by using the Portuguese version of ITAS. The scale was translated based on the model proposed by Wild, et al. and its psychometric properties were assessed. Results. The average Cronbach's α coefficient was 0.830. ITAS and Basel Assessment of Adherence with Immunosuppressive Medications Scale (BAASIS) presented significant correlation, with a Spearman's ρ coefficient = 0.300 (S = 309,580; p ‹ 0.001). The area under the receiver operating characteristics (ROC) curve was 0.638 (95% CI: 0.557 - 0.715). Factor analysis results indicated that the carelessness factor model was the optimal model, and the factor "feeling worse" was the lowest. Conclusion. The Portuguese version of ITAS has adequate psychometric properties to measure adherence to immunosuppressant therapy.

REFERENCES

1. WHO. Adherence to Long-term Therapies. Evidence for Action Switzerland: World Health Organization. 2003.

2. Burra P, Germani G, Gnoato F, Lazzaro S, Russo FP, Cillo U, Senzolo M. Adherence in liver transplant recipients. Liver Transplantation 2011; 17:760-70

3. Stilley CS, DiMartini AF, de Vera ME, Flynn WB, King J, Sereika S, Tarter RE, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Progress in transplantation 2010; 20: 58-67.

4. Laederach-Hofmann K, Bunzel B. Noncompliance in organ transplant recipients: a literature review. General Hospital Psychiatr 2000; 22: 412-24.

5. Germani G, Lazzaro S, Gnoato F, Senzolo M, Borella V, Rupolo G, Cillio U, et al. Nonadherent behaviors after solid organ transplantation. Transplantation Proceedings 2011; 43: 318-23.

6. Serper M, Patzer RE, Reese PP, Przytula K, Koval R, Ladner DP, Levitsky J, et al. Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients. Liver transplantation 2015; 21(1): 22-8.

7. De Oliveira PC, Mucci S, Silva ESV, Leite RF, Paglione HB, Erbs JL, Araujo CAS, et al. Assessment of Factors Related to Adherence to Treatment in Liver Transplantation Candidates. Transplantation proceedings 2016; 48: 2361-5.

8. Dew MA, DiMartini AF, De Vito Dabbs A, Myaskovsky L, Steel J, Unruh M, Switzer GE, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 15; 83: 858-73.

9. Osterberg L, Blaschke T. Adherence to Medication. N Eng J Med 2005; 353: 487-97.

10. Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, Aikens JE, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Translational Behavioral Medicin 2015; 5: 470- 82.

11. Leven EA, Annunziato R, Helcer J, Lieber SR, Knight CS, Wlodarkiewicz C, Soriano RP, et al. Medication adherence and rejection rates in older vs younger adult liver transplant recipients. Clinical transplantation 2017.

12. Asavakarn S, Sirivatanauksorn Y, Promraj R, Ruenrom A, Limsrichamrern S, Kositamongkol P, Mahawithitwong P, et al. Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients. Transplantation proceedings 2016; 48: 1202-7.

13. Pacheco L. Liver transplantation in Brazil. Revista do Colégio Brasileiro de Cirurgiões 2016; 43: 223-4.

14. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Education and Counseling 2005; 59: 13-20.

15. Wilks SE, Spivey CA, Chisholm-Burns MA. Psychometric reevaluation of the immunosuppressant therapy adherence scale among solid-organ transplant recipients. J Evaluation in Clinical Practice 2010; 16: 64-8.

16. Marsicano E de O, Fernandes Nda S, Colugnati F, Grincenkov FR, Fernandes NM, De Geest S, Sanders-Pinheiro H. Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrology 2013; 14: 108.

17. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee- Lorenz A, Erikson P, et al. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005; 8: 94-104.

18. Gadermann AM, Guhn M, Zumbo BD. Estimating Ordinal Reliability for Likert-Type and Ordinal Item Response Data: A Conceptual, Empirical, and Practical Guide. Practical Assessment, Research & Evaluation 2012; 17: 1-13.

19. Marsicano EO, Fernandes NS, Colugnati FA, Fernandes NM, De Geest S, Sanders-Pinheiro H. Multilevel Correlates of Non-Adherence in Kidney Transplant Patients Benefitting from Full Cost Coverage for Immunosuppressives: A Cross- Sectional Study. PLoS One 2015; 10: e0138869.

20. Tielen M, Van Exel J. Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study. J Transplant 2014; 2014: 675301.

21. R Development Core Team R. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2011.

22. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. AJHP 2005; 62: 1775-81.

23. Promraj R, Dumronggittigule W, Sirivatanauksorn Y, Ruenrom A, Tovikkai C, Limsrichamrern S, Kositamongkol P, et al. Immunosuppressive Medication Adherence in Liver Transplant Recipients. Transplantation Proceeding 2016; 48: 1198-201

24. Tsapepas D, Langone A, Chan L, Wiland A, McCague K, Chisholm-Burns M. A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational REnal Transplant (MORE) study. Ann Transplant 2014; 19: 174-81.

25. Sankaranarayanan J, Collier D, Furasek A, Reardon T, Smith LM, McCartan M, Langnas AN. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients. Research in Social and Administrative Pharmacy 2012; 8: 228-39.

26. Kimberlin CL, Winterstein AG. Validity and reliability of measurement instruments used in research. Am J Health System Pharmacy 2008; 65: 2276-84.

27. Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Medical Education 2011; 2: 53-5.

28. Hajian-Tilaki K. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Internal Medicine 2013; 4: 627-35.